As of Aug 21
| +0.74 / +1.06%|
The 20 analysts offering 12-month price forecasts for AbbVie have a median target of 73.00, with a high estimate of 95.00 and a low estimate of 60.00. The median estimate represents a +3.25% increase from the last price of 70.70.
The current consensus among 23 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.